18F-FDG PET/CT is a prognostic bio-marker in patients affected by bone metastases from breast cancer. Comparison with 18F-NaF-PET/CT.

被引：0
|
作者：
Piccardo, A. [1 ]
Massollo, M. [1 ]
Altrinetti, V. [1 ]
Morbelli, S. [2 ]
Bongioanni, F. [2 ]
Iacozzi, M. [1 ]
Sambuceti, G. [2 ]
Gennari, A. [3 ]
Gonella, R. [4 ]
Puntoni, M. [5 ]
Decensi, A. [3 ]
Cabria, M. [1 ]
机构：
[1] EO Osped Galliera, Nucl Med Unit, Genoa, Italy
[2] San Martino IST, Nucl Med Unit, Genoa, Italy
[3] EO Osped Galliera, Oncol Unit, Genoa, Italy
[4] San Martino IST, Dept Internal Med, Genoa, Italy
[5] Galliera Hosp, Clin Trial Res Unit, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P587
引用
收藏
页码：S619 / S620
页数：2
相关论文
共 50 条
  • [1] 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT
    Piccardo, A.
    Puntoni, M.
    Morbelli, S.
    Massollo, M.
    Bongioanni, F.
    Paparo, F.
    Altrinetti, V.
    Gonella, R.
    Gennari, A.
    Iacozzi, M.
    Sambuceti, G.
    DeCensi, A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (04): : 163 - 172
  • [2] Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer
    Roop, Mohan J.
    Singh, Baljinder
    Singh, Harmandeep
    Watts, Ankit
    Kohli, Pavneet S.
    Mittal, Bhagwant R.
    Singh, Gurpreet
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 335 - 340
  • [3] 18F NaF PET/MR for the evaluation of bone metastases in breast cancer patients: Comparison to NaF PET/CT, FDG PET/CT, and MDP bone scan.
    Bucklan, Daniel
    Muzic, Raymond
    Faulhaber, Peter
    Jones, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [4] 18F-FDG PET/CT versus 18F-Fluoride PET/CT for Detecting Bone Metastases in Patients With Breast Cancer and Equivocal Bone Scan
    Brito, A. E.
    Almeida, R. G.
    Mosci, C.
    Lima, M. C. L.
    Amorim, B. J.
    Santos, A. O.
    Souza, T. F.
    Brunetto, S. Q.
    Etchebehere, E. C.
    Ramos, C. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S273 - S274
  • [5] Vanishing Bone Metastases in 18F-FDG PET/CT
    Ainouche, Alida
    Morland, David
    Durot, Carole
    Hoeffel, Christine
    Papathanassiou, Dimitri
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 559 - 560
  • [6] Comparative analysis of 18F-FDG and 18F-NaF PET/CT in detecting osseous metastases in breast cancer
    Chaudhry, Muhammad
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [7] Correlation of Breast Cancer Subgroups and Axillary Metastases with 18F-FDG PET/CT and the Contribution of 18F-FDG PET/CT in the Management of the Axilla
    Ozer, Nazmi
    Sahin, Abdullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (02): : 150 - 155
  • [8] Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT, and bone scintigraphy in detection of bone metastases of differentiated thyroid cancer
    Ota, N.
    Kato, K.
    Iwano, S.
    Ito, S.
    Tsuchiya, K.
    Okochi, Y.
    Okada, Y.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S383 - S383
  • [9] Diagnostic Value of 18F-FDG PET/CT in Comparison to Bone Scintigraphy, CT and 18F-FDG PET for the Detection of Bone Metastasis
    Liu, Ning-Bo
    Zhu, Lei
    Li, Ming-Huan
    Sun, Xiao-Rong
    Hu, Man
    Huo, Zong-Wei
    Xu, Wen-Gui
    Yu, Jin-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3647 - 3652
  • [10] Comparison of 18F-FLT PET/CT and 18F-FDG PET/CT in detection of metastases of differentiated thyroid cancer
    Kato, K.
    Abe, S.
    Odagawa, T.
    Fujita, Y.
    Niwa, A.
    Iwano, S.
    Ito, S.
    Ikeda, M.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S263 - S263
12345